Commercializing Innovation: Prof. Doug Melton and Semma Therapeutics

Date: 

Monday, April 24, 2017, 4:00pm to 6:00pm

Location: 

Biolabs 1080, 16 Divinity Ave., Cambridge, MA 02138

ORGANIZATION/SPONSOR: Harvard Office of Technology Development and the FAS Office of Postdoctoral Affairs
SPEAKER(S): Prof. Douglas Melton (Harvard University); Semma Therapeutics CEO Robert Millman; and Semma VP and former Harvard postdoc Felicia Pagliuca.
COST: Free
TICKET WEB LINK: melton-semma.eventbrite.com
CONTACT INFO: otd@harvard.edu
DETAILS:    
Harvard-launched startup Semma Therapeutics has licensed innovations from Prof. Doug Melton’s lab that enable the generation of billions of functional, insulin-producing beta cells in the laboratory. Join us to hear a discussion with the cofounders.
The Commercializing Innovation speaker series is primarily intended for Harvard University faculty, postdoctoral researchers, and graduate students who are interested in learning about technology commercialization, careers outside of academia, and scientific entrepreneurship. However, the event is open to all.
LINK: otd.harvard.edu

See also: Lecture